BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 23082473)

  • 1. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
    el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
    Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
    Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
    Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.
    Hassanein NM; Perkinson KR; Alcancia F; Goodman BK; Weinberg JB; Lagoo AS
    Am J Clin Pathol; 2010 May; 133(5):708-17. PubMed ID: 20395517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
    Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
    Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
    Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
    Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.
    Dickinson JD; Gilmore J; Iqbal J; Sanger W; Lynch JC; Chan J; Bierman PJ; Joshi SS
    Leuk Lymphoma; 2006 Feb; 47(2):231-44. PubMed ID: 16321852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
    Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).
    Del Giudice I; Davis Z; Matutes E; Osuji N; Parry-Jones N; Morilla A; Brito-Babapulle V; Oscier D; Catovsky D
    Leukemia; 2006 Jul; 20(7):1231-7. PubMed ID: 16642047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.
    Del Principe MI; Del Poeta G; Venditti A; Buccisano F; Maurillo L; Marini R; Cox MC; Panetta P; Suppo G; Degan M; Bruno A; Gattei V; Amadori S
    Haematologica; 2004 Dec; 89(12):1468-75. PubMed ID: 15590397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of molecular cytogenetic abnormalities in 30 patients with chronic lymphocytic leukemia by fluorescence in situ hybridization].
    Dai D; Zhang XQ; Zhang XZ; Su AL; Zhang L; Cao SB; Xu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):31-5. PubMed ID: 19236742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
    Rivkina A; Vitols G; Murovska M; Lejniece S
    Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Tian T; Li L; Qiu HX
    Leuk Res; 2009 Feb; 33(2):237-43. PubMed ID: 18674817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
    Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
    Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
    Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
    Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.